These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19710996)

  • 1. Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances.
    Pérez V; Marin C; Rubio A; Aguilar E; Barbanoj M; Kulisevsky J
    J Neural Transm (Vienna); 2009 Oct; 116(10):1257-66. PubMed ID: 19710996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease.
    Marin C; Bonastre M; Mengod G; Cortés R; Rodríguez-Oroz MC; Obeso JA
    Exp Neurol; 2013 Dec; 250():304-12. PubMed ID: 24140562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
    Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of locus coeruleus denervation on levodopa-induced motor fluctuations in hemiparkinsonian rats.
    Marin C; Aguilar E; Bonastre M
    J Neural Transm (Vienna); 2008 Aug; 115(8):1133-9. PubMed ID: 18528630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on L-Dopa induced dyskinesia.
    Rentsch P; Stayte S; Morris GP; Vissel B
    BMC Neurosci; 2019 Feb; 20(1):5. PubMed ID: 30760214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
    Shin E; Rogers JT; Devoto P; Björklund A; Carta M
    Exp Neurol; 2014 Jul; 257():25-38. PubMed ID: 24747357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.
    Winkler C; Kirik D; Björklund A; Cenci MA
    Neurobiol Dis; 2002 Jul; 10(2):165-86. PubMed ID: 12127155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional noradrenergic depletion aggravates forelimb akinesia and abnormal subthalamic nucleus activity in a rat model of Parkinson's disease.
    Wang Y; Chen X; Wang T; Sun YN; Han LN; Li LB; Zhang L; Wu ZH; Huang C; Liu J
    Life Sci; 2014 Dec; 119(1-2):18-27. PubMed ID: 25445222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and blockade of serotonin
    Guo Y; Zhang L; Zhang J; Du CX; Lv SX; Wang T; Wang HS; Xie W; Liu J
    Neurol Res; 2019 Jul; 41(7):585-593. PubMed ID: 30929589
    [No Abstract]   [Full Text] [Related]  

  • 12. l-dopa-induced dyskinesias in unilateral 6-hydroxydopamine-lesioned rats are not modified by excitotoxic lesion of the entopeduncular nucleus and substantia nigra pars reticulata.
    Gago B; Marin C; Rodríguez-Oroz MC; Obeso JA
    Synapse; 2013 Jul; 67(7):407-14. PubMed ID: 23404474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopaminergic fiber recovery after acute L-DOPA treatment in 6-hydroxydopamine (6-OHDA) lesioned rats.
    Fang C; Yin J; Xu Z; Wang Y; Xu H; Zhou H; Gao C
    Cell Biochem Biophys; 2011 Jan; 59(1):49-56. PubMed ID: 20714825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
    Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
    Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of alpha2-adrenoceptors in normal and medial forebrain bundle lesioned rats.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Wang T; Chen L; Li Q
    Brain Res; 2010 Apr; 1324():64-74. PubMed ID: 20153300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias.
    Paillé V; Henry V; Lescaudron L; Brachet P; Damier P
    Mov Disord; 2007 Mar; 22(4):533-9. PubMed ID: 17230470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wu ZH; Li Q
    Brain Res; 2010 Jan; 1310():189-99. PubMed ID: 19896932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
    Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease.
    Paillé V; Brachet P; Damier P
    Neuroreport; 2004 Mar; 15(3):561-4. PubMed ID: 15094523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term unilateral 6-hydroxydopamine lesions in rats show different changes in characteristics of spontaneous firing of substantia nigra pars reticulata neurons.
    Seeger-Armbruster S; von Ameln-Mayerhofer A
    Exp Brain Res; 2013 Jan; 224(1):15-24. PubMed ID: 23283416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.